Gavi: 7m Nigerian girls vaccinated against HPV in two weeks

Gavi, the vaccine alliance, says seven million Nigerian girls have been vaccinated against human papillomavirus (HPV) in two weeks.

The HPV vaccines prevent infection by certain types of human papillomavirus, a common sexually transmitted disease that can cause a range of conditions in men and women, such as cervical cancer.

In a statement on Wednesday, the vaccine alliance said the “achievement marks a significant milestone in Nigeria’s fight against cervical cancer”.

Gavi added that the achievement marks a significant milestone in Nigeria’s fight against cervical cancer.

“Cervical cancer is the second most prevalent cancer among women in Nigeria, claiming countless lives each year,” the statement reads.

“The HPV vaccine offers a highly effective tool for prevention, with an average success rate of 92%.

“In October 2023, Gavi partnered with the Nigerian Ministry of Health and Social Welfare, the National Primary Health Care Development Agency, WHO, and UNICEF to introduce the HPV vaccine into the national immunization program.

“Building on this success, Gavi further expanded its collaboration with Girl Effect in May 2024 to focus on reaching girls with critical information and ensuring vaccine access.

“By vaccinating seven million girls in just two weeks, Nigeria has made significant progress towards its goal of reaching 16 million girls by 2025.”

Speaking on the development, Sani Nishtar, the chief executive officer (CEO) of Gavi, said the achievement is a testament to the tremendous collaboration between the vaccine alliance, the Nigerian government, and its partners.

“By prioritising girls’ health, we are empowering a generation and helping to save countless lives,” Nishtar said.